Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees?

被引:0
作者
Stefan Löb
Alfred Königsrainer
Hans-Georg Rammensee
Gerhard Opelz
Peter Terness
机构
[1] Visceral and Transplant Surgery,Stefan Löb and Alfred Königsrainer are at the Department of General
[2] University Hospital of Tubingen,Department of Immunology
[3] Hoppe-Seyler-Strasse 3,Department of Transplantation Immunology
[4] 72076 Tubingen,undefined
[5] Germany.,undefined
[6] Hans-Georg Rammensee is at the Institute of Cell Biology,undefined
[7] University of Tubingen,undefined
[8] Auf der Morgenstelle 15,undefined
[9] 72076 Tubingen,undefined
[10] Germany.,undefined
[11] Gerhard Opelz and Peter Terness are at the Institute of Immunology,undefined
[12] University of Heidelberg,undefined
[13] INF-305,undefined
[14] 69120 Heidelberg,undefined
[15] Germany.,undefined
来源
Nature Reviews Cancer | 2009年 / 9卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Indoleamine-2,3-dioxygenase (IDO) is an immunosuppressive enzyme that is expressed in tumours and enables them to escape immunologically mediated rejection. However, we are far from understanding the biological relevance of IDO expression during tumorigenesis. We need a better understanding of IDO biology to provide a rationale for the use of IDO inhibitors in the clinic.
引用
收藏
页码:445 / 452
页数:7
相关论文
共 251 条
[1]  
Moffett JR(2003)Tryptophan and the immune response Immunol. Cell Biol. 81 247-265
[2]  
Namboodiri MA(1984)Interferon gamma blocks the growth of Proc. Natl Acad. Sci. USA 81 908-912
[3]  
Pfefferkorn ER(1978) in human fibroblasts by inducing the host cells to degrade tryptophan Proc. Natl Acad. Sci. USA 75 3998-4000
[4]  
Yoshida R(1979)Induction of pulmonary indoleamine 2,3-dioxygenase by intraperitoneal injection of bacterial lipopolysaccharide Proc. Natl Acad. Sci. USA 76 4084-4086
[5]  
Hayaishi O(1998)Induction of indoleamine 2,3-dioxygenase in mouse lung during virus infection Science 281 1191-1193
[6]  
Yoshida R(2005)Prevention of allogeneic fetal rejection by tryptophan catabolism Nature Rev. Cancer 5 263-274
[7]  
Urade Y(1999)Immunosuppressive networks in the tumour environment and their therapeutic relevance J. Exp. Med. 189 1363-1372
[8]  
Tokuda M(2002)Inhibition of T cell proliferation by macrophage tryptophan catabolism Immunology 107 452-460
[9]  
Hayaishi O(2005)Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division Immunity 22 633-642
[10]  
Munn DH(2002)GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase J. Exp. Med. 196 459-468